Syaloset Plus Syringe Hyaluronic Acid 1,5% 4ml

Syaloset injected directly into the joint, performs a viscosupplective action improving the properties À lubricants and shock absorption of the synovial fluid. È a new generation product which, administered under medical observation, restores viscosity; of the synovial fluid, allowing a return to normal activities.

Composition
Sodium hyaluronate: 16 mg Sodium chloride: 8.5 mg Sodium phosphate dibasic dihydrate : 0.563 mg Sodium dihydrogen phosphate monohydrate: 0.0045 mg Water for injections qs 1 ml Syaloset È produced in an aseptic environment and terminally sterilized.

Mode À of use
Aspirate any joint effusion before proceeding with the injection. Insert a sterile needle of diameter (18 G) on the syringe. Screw the needle firmly onto the syringe collar to ensure a watertight seal and then withdraw the sterile hyaluronic acid solution from the vial. Replace the needle with a suitable sterile needle (21 G) and screw the needle firmly to the syringe collar to ensure a watertight seal and prevent liquid leakage during administration and then inject Syaloset into the arthritic joint. Inject only into the synovial space. È recommended to repeat the treatment of the knee after 3-6 weeks in order to obtain a long-term improvement of the symptoms. The opportunity and the frequency with which you can Ò repeating the course of treatment must be evaluated by the physician for each individual patient, considering in each case the risk / benefit ratio of the treatment. For the hip joint, it is recommended to inject the product under ultrasound guidance.

Warnings
the administration of the product must only be performed by medical specialists.
All rules regarding asepsis and injection techniques must be observed. If È if there is a spill, remove it before administering the product.
Do not mix Syaloset with disinfectants such as quaternary ammonium salts or chlorhexidine since É can Ò form a precipitate. Avoid the simultaneous administration of Sualoset with other products for intra-articular use, in order to prevent any possible interaction.
The device is; intended for single use only and the contents must be used immediately after aspiration, removing any air bubbles.
The injection site must be on healthy skin.
Do not inject by vascular route.
Do not inject outside the cavity; joint, synovial tissue or joint capsule.
Do not administer Syaloset in the presence of profuse intra-articular effusion.
After intra-articular injection, advise the patient to avoid all activities. intense physical activity and to resume normal activities; only after a few days.